This inventor holds 3 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Merck Serono S. a.. Active years: 2013-2015.
Company Filing History:
Years Active: 2013-2015
Title: Michel Kobr: Innovator in Protein Production
Introduction
Michel Kobr is a notable inventor based in Echandens, Switzerland. He has made significant contributions to the field of protein production, holding a total of 3 patents. His work focuses on innovative solutions that enhance the efficiency and effectiveness of industrial protein production.
Latest Patents
One of Michel Kobr's latest patents is the Puro-DHFR quadrifunctional marker and its use in protein production. This invention pertains to the industrial production of proteins, specifically involving the res-DHFR surrogate marker. This marker is a fusion between dihydrofolate reductase (DHFR) and a protein that provides resistance to toxic compounds or offers a metabolic advantage. The invention also includes the application of res-DHFR for screening cells that exhibit high expression of a protein of interest. The Puro-DHFR surrogate marker exemplifies this innovation, showcasing a fusion between puromycin N-acetyltransferase and DHFR.
Career Highlights
Michel Kobr is currently associated with Merck Serono S.A., where he continues to advance his research and development efforts in the field of biotechnology. His work at Merck Serono has allowed him to collaborate with leading experts and contribute to groundbreaking advancements in protein production technologies.
Collaborations
Michel Kobr has worked alongside Philippe V Dupraz, enhancing the collaborative efforts in their research initiatives. Their combined expertise has led to significant advancements in their respective fields.
Conclusion
Michel Kobr is a prominent figure in the realm of protein production, with a focus on innovative solutions that address industry challenges. His contributions through patents and collaborations continue to shape the future of biotechnology.